Shopping Cart
- Remove All
Your shopping cart is currently empty
PNB-001 is an orally active, CCK2-selective ligand and antagonist with anti-inflammatory and analgesic activities [1].

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks |
| Description | PNB-001 is an orally active, CCK2-selective ligand and antagonist with anti-inflammatory and analgesic activities [1]. |
| In vitro | PNB-001 (100 nM, 30 min) effectively inhibits the contraction of the duodenum in experimental rats induced by CCK4 and CCK5 [1]. |
| In vivo | PNB-001, administered orally at doses of 5 and 20 mg/kg, exhibits anti-inflammatory activity and protects rats from ulcers induced by indomethacin [1]. |
| Molecular Weight | 313.78 |
| Formula | C18H16ClNO2 |
| Cas No. | 1528760-09-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.